| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
 11 Agents affecting central nervous system
|
12 Agents affecting peripheral nervous system
|
121 Local anesthetics
|
122 Skeletal muscle relaxants
|
123 Autonomic nervous system agents
|
124 Antispasmodics
|
 1241 Diphenylglycolates
|
1242 Atropines
|
D01201 Tiemonium iodide (JAN/INN)
D02069 Atropine sulfate (JP16/USP)
D01451 Scopolamine butylbromide (JP16)
D01976 N-Methylscopolamine methylsulfate (JAN)
D02071 Scopolamine hydrobromide hydrate (JP16); Scopolamine hydrobromide (USP)
D01491 Butropium bromide (JP16/INN)
|
A03AB17
A03BA01 S01FA01
A03BB01
A03BB03 S01FA03
A04AD01 N05CM05 S01FA02
|
1243 Papaverines
|
1244 Magnesium salts
|
1245 Alkaloids
|
1249 Others
|
125 Diaphoretics, anhidrotics
|
129 Miscellaneous
|
13 Agents affecting sensory organs
|
19 Other agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
4 Agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan